CERS
HEALTHCARECerus Corp
$2.59+0.00 (+0.00%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving CERS Today?
No stock-specific AI insight has been generated for CERS yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.15$3.15
$2.59
Fundamentals
Market Cap$519M
P/E Ratio—
EPS$-0.05
Dividend Yield—
Dividend / Share—
ROE-0.2%
Profit Margin-0.0%
Debt / Equity—
Trading
Volume2.1M
Avg Volume (10D)—
Shares Outstanding200.4M
CERS News
20 articles- Cerus Corporation Q1 2026 Earnings Call SummaryMoby·May 1, 2026
- Cerus Corp (CERS) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...Yahoo Finance·May 1, 2026
- Cerus (CERS) Q1 2026 Earnings TranscriptMotley Fool·Apr 30, 2026
- Cerus Q1 Earnings Call HighlightsMarketbeat·Apr 30, 2026
- Cerus Corporation Announces First Quarter 2026 Financial ResultsYahoo Finance·Apr 30, 2026
- Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood SystemYahoo Finance·Apr 27, 2026
- Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026Yahoo Finance·Apr 16, 2026
- Oramed Pharmaceuticals And Two Other Promising Penny Stocks For Savvy InvestorsYahoo Finance·Apr 14, 2026
- Cerus Appoints Vivek Jayaraman as President and Chief Executive OfficerYahoo Finance·Mar 16, 2026
- Cerus Details INTERCEPT Growth Plan, BCA Deal Upside and 2026 RBC Milestones at TD Cowen ConferenceMarketbeat·Mar 8, 2026
- Cerus Corporation Q4 2025 Earnings Call SummaryMoby·Mar 3, 2026
- Cerus Corp (CERS) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...Yahoo Finance·Mar 3, 2026
- Cerus Q4 Earnings Call HighlightsMarketbeat·Mar 2, 2026
- Cerus (CERS) Q4 2025 Earnings Call TranscriptMotley Fool·Mar 2, 2026
- Cerus: Q4 Earnings SnapshotYahoo Finance·Mar 2, 2026
- Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial ResultsYahoo Finance·Mar 2, 2026
- Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care ConferenceYahoo Finance·Feb 20, 2026
- Cerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026Yahoo Finance·Feb 17, 2026
- Promising Penny Stocks To Watch In February 2026Yahoo Finance·Feb 16, 2026
- DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus’ INTERCEPT™ Blood System in Routine Clinical PracticeYahoo Finance·Jan 22, 2026
All 20 articles loaded
Price Data
Open$2.58
Previous Close$2.59
Day High$2.65
Day Low$2.49
52 Week High$3.15
52 Week Low$1.15
52-Week Range
$1.15$3.15
$2.59
Fundamentals
Market Cap$519M
P/E Ratio—
EPS$-0.05
Dividend Yield—
Dividend / Share—
ROE-0.2%
Profit Margin-0.0%
Debt / Equity—
Trading
Volume2.1M
Avg Volume (10D)—
Shares Outstanding200.4M
About Cerus Corp
Cerus Corporation, a biomedical products company, is focused on developing and commercializing the INTERCEPT Blood System to improve blood safety. The company is headquartered in Concord, California.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—